- Home
- GOVX vs CRIS Comparison
GOVX vs CRIS Comparison
Compare GOVX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- CRIS
- Stock Information
- Founded
- GOVX 2001
- CRIS 2000
- Country
- GOVX United States
- CRIS United States
- Employees
- GOVX N/A
- CRIS N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GOVX Health Care
- CRIS Health Care
- Exchange
- GOVX Nasdaq
- CRIS Nasdaq
- Market Cap
- GOVX 16.8M
- CRIS 18.6M
- IPO Year
- GOVX N/A
- CRIS 2000
- Fundamental
- Price
- GOVX $0.51
- CRIS $1.30
- Analyst Decision
- GOVX Strong Buy
- CRIS Strong Buy
- Analyst Count
- GOVX 3
- CRIS 2
- Target Price
- GOVX $10.67
- CRIS $16.50
- AVG Volume (30 Days)
- GOVX 742.0K
- CRIS 74.5K
- Earning Date
- GOVX 11-07-2025
- CRIS 11-06-2025
- Dividend Yield
- GOVX N/A
- CRIS N/A
- EPS Growth
- GOVX N/A
- CRIS N/A
- EPS
- GOVX N/A
- CRIS N/A
- Revenue
- GOVX $6,143,044.00
- CRIS $11,405,000.00
- Revenue This Year
- GOVX N/A
- CRIS $2.72
- Revenue Next Year
- GOVX N/A
- CRIS $8.27
- P/E Ratio
- GOVX N/A
- CRIS N/A
- Revenue Growth
- GOVX 1943.07
- CRIS 12.24
- 52 Week Low
- GOVX $0.43
- CRIS $1.02
- 52 Week High
- GOVX $3.88
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- GOVX 39.70
- CRIS 26.88
- Support Level
- GOVX $0.54
- CRIS $1.46
- Resistance Level
- GOVX $0.61
- CRIS $1.49
- Average True Range (ATR)
- GOVX 0.03
- CRIS 0.09
- MACD
- GOVX -0.00
- CRIS -0.02
- Stochastic Oscillator
- GOVX 14.50
- CRIS 12.72
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.